CompletedNCT00538070
A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia
Placebo comparisonAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Belmont and 1 more locationSee all locations and recruitment
Study information
Study start dateAugust 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 68
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- DIETARY_SUPPLEMENT
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00538070
- Official title
Show the full official title
The Effects of Glycine Transport Inhibition on Brain Glycine Concentration
Get this study by email
Recruitment & locations
CompletedBelmont · Boston
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Who was this study for?
Listed age limits: 18 years to 65 years.
